home / stock / myov / myov news


MYOV News and Press, Myovant Sciences Ltd.

Stock Information

Company Name: Myovant Sciences Ltd.
Stock Symbol: MYOV
Market: NYSE
Website: myovant.com

Menu

MYOV MYOV Quote MYOV Short MYOV News MYOV Articles MYOV Message Board
Get MYOV Alerts

News, Short Squeeze, Breakout and More Instantly...

MYOV - Myovant Sciences, Ltd. (MYOV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

NEW YORK, NY / ACCESSWIRE / October 19, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myovant Sciences, Ltd. ("Myovant" or "the Company") (NYSE:MYOV). Investors who purchased Myovant securities are encouraged to obtain additional infor...

MYOV - Myovant Sciences GAAP EPS of -$0.56 beats by $0.08, revenue of $100.23M misses by $2.13M

Myovant Sciences press release ( NYSE: MYOV ): Q3 GAAP EPS of -$0.56 beats by $0.08 . Revenue of $100.23M (+84.1% Y/Y) misses by $2.13M . Cash, cash equivalents, marketable securities, and amounts available under the Sumitomo Pharma Loan Agreement totaled $315.7 millio...

MYOV - Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022

Third fiscal quarter 2022 total revenue of $100.2 million ; including net product revenue of $61.4 million Net product revenue from U.S. sales of ORGOVYX ® of $48.7 million in third fiscal quarter 2022, with sequential quarterly demand volume ...

MYOV - MYOV SPECIAL ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Take-Private Acquisition of Myovant Sciences

MYOV SPECIAL ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Take-Private Acquisition of Myovant Sciences MYOV SPECIAL ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Take-Private Acquisition of Myovant Sciences PR Newswire ...

MYOV - Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources

BASEL, Switzerland, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) today announced the appointment of Ann Tomlin as Senior Vice President of Human Resources. Beginning November 28, Ms. Tomlin will be responsible for developing talent solutions and human resources strategies...

MYOV - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNBE, BTRS, PEBO, MYOV

NEW YORK, NY / ACCESSWIRE / November 6, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: KnowBe4, Inc. (NASDAQ:KNBE)'s s...

MYOV - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PEBO, LMST, MYOV, USER

NEW YORK, NY / ACCESSWIRE / October 30, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Peoples Bancorp Inc. (NASDAQ:PEBO...

MYOV - Axsome: Ramifications Of Recent Biotech Deals

Summary The macroeconomic factors create a highly favorable mergers and acquisition environment. Several interesting deals are being executed this month. As it's a strong buyers' market, you're likely to see more buyouts going toward year-end and next year. Axsome is an ideal ...

MYOV - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PEBO, LMST, MYOV, IMRA

NEW YORK, NY / ACCESSWIRE / October 28, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Peoples Bancorp Inc. (NASDAQ:PEBO...

MYOV - Myovant Sciences GAAP EPS of -$0.47 beats by $0.02, revenue of $104.8M beats by $11.33M

Myovant Sciences press release ( NYSE: MYOV ): Q2 GAAP EPS of -$0.47 beats by $0.02 . Revenue of $104.8M (+34.5% Y/Y) beats by $11.33M . Cash, cash equivalents, marketable securities, and amounts available under the Sumitomo Pharma Loan Agreement totaled $412.6...

Next 10